{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T14:29:35Z","timestamp":1776954575802,"version":"3.51.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Diabetes has been shown to be independent predictor of restenosis after percutaneous coronary intervention (PCI). The aim of the present study was to investigate whether a pre- and post-procedural glycaemic control in diabetic patients was related to major advance cardiovascular events (MACE) during follow up.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We evaluated 2884 consecutive patients including 2181 non-diabetic patients and 703 diabetics who underwent coronary stenting. Diabetes mellitus was defined as the fasting blood sugar concentration \u2265 126\u2009mg\/dL, or the use of an oral hypoglycemic agent or insulin at the time of admission. Diabetic patients were categorized into two groups based on their mean HbA1c levels for three measurements (at 0, 1, and 6\u2009months following procedure): 291 (41.4%) diabetics with good glycaemic control (HbA1c\u2009\u2264\u20097%) and 412 (58.6%) diabetics with poor glycaemic control (HbA1c\u2009&gt;\u20097%).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The adjusted risk of MACE in diabetic patients with poor glycaemic control (HbA1c\u2009&gt;\u20097%) was 2.1 times of the risk in non-diabetics (adjusted HR\u2009=\u20092.1, 95% CI: 1.10 to 3.95, <jats:italic>p<\/jats:italic>\u2009=\u20090.02). However, the risk of MACE in diabetics with good glycaemic control (HbA1c\u2009\u2264\u20097%) was not significantly different from that of non-diabetics (adjusted HR\u2009=\u20091.33, 95% CI: 0.38 to 4.68, <jats:italic>p<\/jats:italic>\u2009=\u20090.66).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Our data suggest that there is an association between good glycaemic control to obtain HbA1c levels \u22647% (both pre-procedural glycaemic control and post-procedural) with a better clinical outcome after PCI.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1475-2840-11-82","type":"journal-article","created":{"date-parts":[[2012,7,17]],"date-time":"2012-07-17T16:15:36Z","timestamp":1342541736000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting"],"prefix":"10.1186","volume":"11","author":[{"given":"Seyed Ebrahim","family":"Kassaian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamidreza","family":"Goodarzynejad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Ali","family":"Boroumand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojtaba","family":"Salarifar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farzad","family":"Masoudkabir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Reza","family":"Mohajeri-Tehrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamidreza","family":"Pourhoseini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeed","family":"Sadeghian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narges","family":"Ramezanpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Alidoosti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham","family":"Hakki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soheil","family":"Saadat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebrahim","family":"Nematipour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,7,17]]},"reference":[{"key":"509_CR1","unstructured":"Prevention of diabetes mellitus. Report of a WHO study group. World Health Organ Tech Rep Ser 1994, 844:1\u2013100"},{"key":"509_CR2","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1161\/01.CIR.0000140721.27004.4B","volume":"110","author":"DE Cutlip","year":"2004","unstructured":"Cutlip DE, Chhabra AG, Baim DS, Chauhan MS, Marulkar S, Massaro J, Bakhai A, Cohen DJ, Kuntz RE, Ho KK: Beyond restenosis: five-year clinical outcomes from second-generation coronary stent trials. Circulation. 2004, 110: 1226-1230. 10.1161\/01.CIR.0000140721.27004.4B.","journal-title":"Circulation"},{"key":"509_CR3","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1001\/jama.293.12.1501","volume":"293","author":"JD Flaherty","year":"2005","unstructured":"Flaherty JD, Davidson CJ: Diabetes and coronary revascularization. JAMA. 2005, 293: 1501-1508. 10.1001\/jama.293.12.1501.","journal-title":"JAMA"},{"key":"509_CR4","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.amjcard.2006.03.059","volume":"98","author":"TT Lee","year":"2006","unstructured":"Lee TT, Feinberg L, Baim DS, Holmes DR, Aroesty JM, Carrozza JP, Cohen DJ, Ho KK, Cutlip DE: Effect of diabetes mellitus on five-year clinical outcomes after single-vessel coronary stenting (a pooled analysis of coronary stent clinical trials). Am J Cardiol. 2006, 98: 718-721. 10.1016\/j.amjcard.2006.03.059.","journal-title":"Am J Cardiol"},{"key":"509_CR5","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1161\/hc4401.098294","volume":"104","author":"PN Ruygrok","year":"2001","unstructured":"Ruygrok PN, Webster MW, de Valk V, van Es GA, Ormiston JA, Morel MA, Serruys PW: Clinical and angiographic factors associated with asymptomatic restenosis after percutaneous coronary intervention. Circulation. 2001, 104: 2289-2294. 10.1161\/hc4401.098294.","journal-title":"Circulation"},{"key":"509_CR6","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1136\/hrt.2005.070698","volume":"92","author":"C Stettler","year":"2006","unstructured":"Stettler C, Allemann S, Egger M, Windecker S, Meier B, Diem P: Efficacy of drug eluting stents in patients with and without diabetes mellitus: indirect comparison of controlled trials. Heart. 2006, 92: 650-657. 10.1136\/hrt.2005.070698.","journal-title":"Heart"},{"key":"509_CR7","doi-asserted-by":"publisher","first-page":"a1331","DOI":"10.1136\/bmj.a1331","volume":"337","author":"C Stettler","year":"2008","unstructured":"Stettler C, Allemann S, Wandel S, Kastrati A, Morice MC, Schomig A, Pfisterer ME, Stone GW, Leon MB, de Lezo JS: Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis. BMJ. 2008, 337: a1331-10.1136\/bmj.a1331.","journal-title":"BMJ"},{"key":"509_CR8","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jacc.2009.10.014","volume":"55","author":"A Kapur","year":"2010","unstructured":"Kapur A, Hall RJ, Malik IS, Qureshi AC, Butts J, de Belder M, Baumbach A, Angelini G, de Belder A, Oldroyd KG: Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. J Am Coll Cardiol. 2010, 55: 432-440. 10.1016\/j.jacc.2009.10.014.","journal-title":"J Am Coll Cardiol"},{"key":"509_CR9","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.jacc.2009.09.056","volume":"55","author":"HL Dauerman","year":"2010","unstructured":"Dauerman HL: Percutaneous coronary intervention, diabetes mellitus, and death. J Am Coll Cardiol. 2010, 55: 1076-1079. 10.1016\/j.jacc.2009.09.056.","journal-title":"J Am Coll Cardiol"},{"key":"509_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2840-9-1","volume":"9","author":"A Takara","year":"2010","unstructured":"Takara A, Ogawa H, Endoh Y, Mori F, Yamaguchi J, Takagi A, Koyanagi R, Shiga T, Kasanuki H, Hagiwara N: Long-term prognosis of diabetic patients with acute myocardial infarction in the era of acute revascularization. Cardiovasc Diabetol. 2010, 9: 1-10.1186\/1475-2840-9-1.","journal-title":"Cardiovasc Diabetol"},{"key":"509_CR11","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1161\/01.CIR.95.6.1366","volume":"95","author":"R Kornowski","year":"1997","unstructured":"Kornowski R, Mintz GS, Kent KM, Pichard AD, Satler LF, Bucher TA, Hong MK, Popma JJ, Leon MB: Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. A serial intravascular ultrasound study. Circulation. 1997, 95: 1366-1369. 10.1161\/01.CIR.95.6.1366.","journal-title":"Circulation"},{"key":"509_CR12","doi-asserted-by":"publisher","first-page":"390","DOI":"10.7326\/0003-4819-91-3-390","volume":"91","author":"PJ Dunn","year":"1979","unstructured":"Dunn PJ, Cole RA, Soeldner JS, Gleason RE: Reproducibility of hemoglobin AIc and sensitivity to various degrees of glucose intolerance. Ann Intern Med. 1979, 91: 390-396.","journal-title":"Ann Intern Med"},{"key":"509_CR13","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1056\/NEJM198402093100602","volume":"310","author":"DM Nathan","year":"1984","unstructured":"Nathan DM, Singer DE, Hurxthal K, Goodson JD: The clinical information value of the glycosylated hemoglobin assay. N Engl J Med. 1984, 310: 341-346. 10.1056\/NEJM198402093100602.","journal-title":"N Engl J Med"},{"key":"509_CR14","doi-asserted-by":"publisher","first-page":"434","DOI":"10.2337\/diacare.16.2.434","volume":"16","author":"J Stamler","year":"1993","unstructured":"Stamler J, Vaccaro O, Neaton JD, Wentworth D: Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993, 16: 434-444. 10.2337\/diacare.16.2.434.","journal-title":"Diabetes Care"},{"key":"509_CR15","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1161\/CIRCOUTCOMES.110.957951","volume":"4","author":"U Dafni","year":"2011","unstructured":"Dafni U: Landmark analysis at the 25-year landmark point. Circ Cardiovasc Qual Outcomes. 2011, 4: 363-371. 10.1161\/CIRCOUTCOMES.110.957951.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"509_CR16","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s003950050180","volume":"95","author":"C Indolfi","year":"2000","unstructured":"Indolfi C, Esposito G, Stabile E, Cavuto L, Pisani A, Coppola C, Torella D, Perrino C, Di Lorenzo E, Curcio A: A new rat model of small vessel stenting. Basic Res Cardiol. 2000, 95: 179-185. 10.1007\/s003950050180.","journal-title":"Basic Res Cardiol"},{"key":"509_CR17","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1136\/heart.89.2.218","volume":"89","author":"MR Bennett","year":"2003","unstructured":"Bennett MR: In-stent stenosis: pathology and implications for the development of drug eluting stents. Heart. 2003, 89: 218-224. 10.1136\/heart.89.2.218.","journal-title":"Heart"},{"key":"509_CR18","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1161\/01.CIR.103.24.2980","volume":"103","author":"C Indolfi","year":"2001","unstructured":"Indolfi C, Torella D, Cavuto L, Davalli AM, Coppola C, Esposito G, Carriero MV, Rapacciuolo A, Di Lorenzo E, Stabile E: Effects of balloon injury on neointimal hyperplasia in streptozotocin-induced diabetes and in hyperinsulinemic nondiabetic pancreatic islet-transplanted rats. Circulation. 2001, 103: 2980-2986. 10.1161\/01.CIR.103.24.2980.","journal-title":"Circulation"},{"key":"509_CR19","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jacc.2003.06.019","volume":"43","author":"RA Corpus","year":"2004","unstructured":"Corpus RA, George PB, House JA, Dixon SR, Ajluni SC, Devlin WH, Timmis GC, Balasubramaniam M, O\u2019Neill WW: Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention. J Am Coll Cardiol. 2004, 43: 8-14. 10.1016\/j.jacc.2003.06.019.","journal-title":"J Am Coll Cardiol"},{"key":"509_CR20","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1136\/hrt.2003.030437","volume":"90","author":"C Briguori","year":"2004","unstructured":"Briguori C, Condorelli G, Airoldi F, Mikhail GW, Ricciardelli B, Colombo A: Impact of glycaemic and lipid control on outcome after percutaneous coronary interventions in diabetic patients. Heart. 2004, 90: 1481-1482. 10.1136\/hrt.2003.030437.","journal-title":"Heart"},{"key":"509_CR21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000314331","volume":"116","author":"H Ueda","year":"2010","unstructured":"Ueda H, Mitsusada N, Harimoto K, Miyawaki M, Yasuga Y, Hiraoka H: Glycosylated hemoglobin is a predictor of major adverse cardiac events after drug-eluting stent implantation in patients with diabetes mellitus. Cardiology. 2010, 116: 51-57. 10.1159\/000314331.","journal-title":"Cardiology"},{"key":"509_CR22","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00380-007-1021-x","volume":"23","author":"T Kasai","year":"2008","unstructured":"Kasai T, Miyauchi K, Kajimoto K, Kubota N, Kurata T, Daida H: Influence of diabetes on >10-year outcomes after percutaneous coronary intervention. Hear Vessel. 2008, 23: 149-154. 10.1007\/s00380-007-1021-x.","journal-title":"Hear Vessel"},{"key":"509_CR23","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/MCA.0b013e328342c760","volume":"22","author":"G Cicek","year":"2011","unstructured":"Cicek G, Uyarel H, Ergelen M, Ayhan E, Abanonu GB, Eren M, Gibson CM: Hemoglobin A1c as a prognostic marker in patients undergoing primary angioplasty for acute myocardial infarction. Coron Artery Dis. 2011, 22: 131-137. 10.1097\/MCA.0b013e328342c760.","journal-title":"Coron Artery Dis"},{"key":"509_CR24","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.amjcard.2003.08.008","volume":"92","author":"RA Corpus","year":"2003","unstructured":"Corpus RA, O\u2019Neill WW, Dixon SR, Timmis GC, Devlin WH: Relation of hemoglobin A1c to rate of major adverse cardiac events in nondiabetic patients undergoing percutaneous coronary revascularization. Am J Cardiol. 2003, 92: 1282-1286. 10.1016\/j.amjcard.2003.08.008.","journal-title":"Am J Cardiol"},{"key":"509_CR25","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1056\/NEJMe0803831","volume":"358","author":"WT Cefalu","year":"2008","unstructured":"Cefalu WT: Glycemic targets and cardiovascular disease. N Engl J Med. 2008, 358: 2633-2635. 10.1056\/NEJMe0803831.","journal-title":"N Engl J Med"},{"key":"509_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1475-2840-9-45","volume":"9","author":"LR Kurukulasuriya","year":"2010","unstructured":"Kurukulasuriya LR, Sowers JR: Therapies for type 2 diabetes: lowering HbA1c and associated cardiovascular risk factors. Cardiovasc Diabetol. 2010, 9: 45-10.1186\/1475-2840-9-45.","journal-title":"Cardiovasc Diabetol"},{"key":"509_CR27","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1475-2840-10-98","volume":"10","author":"Y Liu","year":"2011","unstructured":"Liu Y, Yang YM, Zhu J, Tan HQ, Liang Y, Li JD: Prognostic significance of hemoglobin A1c level in patients hospitalized with coronary artery disease. A systematic review and meta-analysis. Cardiovasc Diabetol. 2011, 10: 98-10.1186\/1475-2840-10-98.","journal-title":"Cardiovasc Diabetol"},{"key":"509_CR28","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/1475-2840-9-75","volume":"9","author":"S Kitada","year":"2010","unstructured":"Kitada S, Otsuka Y, Kokubu N, Kasahara Y, Kataoka Y, Noguchi T, Goto Y, Kimura G, Nonogi H: Post-load hyperglycemia as an important predictor of long-term adverse cardiac events after acute myocardial infarction: a scientific study. Cardiovasc Diabetol. 2010, 9: 75-10.1186\/1475-2840-9-75.","journal-title":"Cardiovasc Diabetol"},{"key":"509_CR29","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1067\/mhj.2001.111957","volume":"141","author":"D Hasdai","year":"2001","unstructured":"Hasdai D, Rizza RA, Grill DE, Scott CG, Garratt KN, Holmes DR: Glycemic control and outcome of diabetic patients after successful percutaneous coronary revascularization. Am Heart J. 2001, 141: 117-123. 10.1067\/mhj.2001.111957.","journal-title":"Am Heart J"},{"key":"509_CR30","doi-asserted-by":"publisher","first-page":"501","DOI":"10.2165\/00044011-200828080-00005","volume":"28","author":"AB Kauffman","year":"2008","unstructured":"Kauffman AB, Delate T, Olson KL, Cymbala AA, Hutka KA, Kasten SL, Rasmussen JR: Relationship between haemoglobin A1C values and recurrent cardiac events: a retrospective, longitudinal cohort study. Clin Drug Investig. 2008, 28: 501-507. 10.2165\/00044011-200828080-00005.","journal-title":"Clin Drug Investig"},{"key":"509_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.carrev.2006.10.002","volume":"8","author":"J Lindsay","year":"2007","unstructured":"Lindsay J, Sharma AK, Canos D, Nandalur M, Pinnow E, Apple S, Ruotolo G, Wijetunga M, Waksman R: Preprocedure hyperglycemia is more strongly associated with restenosis in diabetic patients after percutaneous coronary intervention than is hemoglobin A1C. Cardiovasc Revasc Med. 2007, 8: 15-20. 10.1016\/j.carrev.2006.10.002.","journal-title":"Cardiovasc Revasc Med"},{"key":"509_CR32","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ejvs.2006.01.011","volume":"32","author":"CJ O\u2019Sullivan","year":"2006","unstructured":"O\u2019Sullivan CJ, Hynes N, Mahendran B, Andrews EJ, Avalos G, Tawfik S, Lowery A, Sultan S: Haemoglobin A1c (HbA1C) in non-diabetic and diabetic vascular patients. Is HbA1C an independent risk factor and predictor of adverse outcome?. Eur J Vasc Endovasc Surg. 2006, 32: 188-197. 10.1016\/j.ejvs.2006.01.011.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"509_CR33","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.amjcard.2009.02.060","volume":"104","author":"G Lemesle","year":"2009","unstructured":"Lemesle G, Bonello L, de Labriolle A, Maluenda G, Syed AI, Collins SD, Ben-Dor I, Torguson R, Kaneshige K, Xue Z: Prognostic value of hemoglobin A1C levels in patients with diabetes mellitus undergoing percutaneous coronary intervention with stent implantation. Am J Cardiol. 2009, 104: 41-45. 10.1016\/j.amjcard.2009.02.060.","journal-title":"Am J Cardiol"},{"key":"509_CR34","doi-asserted-by":"crossref","unstructured":": Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998, 352: 837-853.","DOI":"10.1016\/S0140-6736(98)07019-6"},{"key":"509_CR35","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","volume":"358","author":"HC Gerstein","year":"2008","unstructured":"Gerstein HC, Miller ME, Byington RP, Goff DC, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH: Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008, 358: 2545-2559.","journal-title":"N Engl J Med"},{"key":"509_CR36","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1056\/NEJMicm066227","volume":"358","author":"A Patel","year":"2008","unstructured":"Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D: Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008, 358: 2560-2572.","journal-title":"N Engl J Med"},{"key":"509_CR37","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1056\/NEJMoa0808431","volume":"360","author":"W Duckworth","year":"2009","unstructured":"Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R: Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009, 360: 129-139. 10.1056\/NEJMoa0808431.","journal-title":"N Engl J Med"},{"key":"509_CR38","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1253\/circj.CJ-10-0474","volume":"75","author":"A Ike","year":"2011","unstructured":"Ike A, Nishikawa H, Shirai K, Mori K, Kuwano T, Fukuda Y, Takamiya Y, Yanagi D, Kubota K, Tsuchiya Y: Impact of glycemic control on the clinical outcome in diabetic patients with percutaneous coronary intervention\u2013from the FU-registry. Circ J. 2011, 75: 791-799. 10.1253\/circj.CJ-10-0474.","journal-title":"Circ J"},{"key":"509_CR39","first-page":"129","volume":"4","author":"SP Marso","year":"1999","unstructured":"Marso SP, Mak KH, Topol EJ: Diabetes mellitus: biological determinants of atherosclerosis and restenosis. Semin Interv Cardiol. 1999, 4: 129-143.","journal-title":"Semin Interv Cardiol"},{"key":"509_CR40","doi-asserted-by":"publisher","first-page":"104","DOI":"10.7326\/0003-4819-124-1_Part_2-199601011-00005","volume":"124","author":"S Genuth","year":"1996","unstructured":"Genuth S: Exogenous insulin administration and cardiovascular risk in non-insulin-dependent and insulin-dependent diabetes mellitus. Ann Intern Med. 1996, 124: 104-109.","journal-title":"Ann Intern Med"},{"key":"509_CR41","doi-asserted-by":"publisher","first-page":"S346","DOI":"10.1016\/S0002-8703(99)70034-7","volume":"138","author":"MN Feinglos","year":"1999","unstructured":"Feinglos MN, Bethel MA: Therapy of type 2 diabetes, cardiovascular death, and the UGDP. Am Heart J. 1999, 138: S346-S352.","journal-title":"Am Heart J"},{"key":"509_CR42","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0735-1097(95)00126-K","volume":"26","author":"K Malmberg","year":"1995","unstructured":"Malmberg K, Ryden L, Efendic S, Herlitz J, Nicol P, Waldenstrom A, Wedel H, Welin L: Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1\u2009year. J Am Coll Cardiol. 1995, 26: 57-65. 10.1016\/0735-1097(95)00126-K.","journal-title":"J Am Coll Cardiol"},{"key":"509_CR43","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1093\/eurheartj\/ehi199","volume":"26","author":"K Malmberg","year":"2005","unstructured":"Malmberg K, Ryden L, Wedel H, Birkeland K, Bootsma A, Dickstein K, Efendic S, Fisher M, Hamsten A, Herlitz J: Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J. 2005, 26: 650-661. 10.1093\/eurheartj\/ehi199.","journal-title":"Eur Heart J"},{"key":"509_CR44","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/01.CCM.0000045568.12881.10","volume":"31","author":"G Van den Berghe","year":"2003","unstructured":"Van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P: Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med. 2003, 31: 359-366. 10.1097\/01.CCM.0000045568.12881.10.","journal-title":"Crit Care Med"},{"key":"509_CR45","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/S0735-1097(98)00286-1","volume":"32","author":"A Abizaid","year":"1998","unstructured":"Abizaid A, Kornowski R, Mintz GS, Hong MK, Abizaid AS, Mehran R, Pichard AD, Kent KM, Satler LF, Wu H: The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol. 1998, 32: 584-589. 10.1016\/S0735-1097(98)00286-1.","journal-title":"J Am Coll Cardiol"},{"key":"509_CR46","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1016\/S0735-1097(00)00574-X","volume":"35","author":"J Schofer","year":"2000","unstructured":"Schofer J, Schluter M, Rau T, Hammer F, Haag N, Mathey DG: Influence of treatment modality on angiographic outcome after coronary stenting in diabetic patients: a controlled study. J Am Coll Cardiol. 2000, 35: 1554-1559. 10.1016\/S0735-1097(00)00574-X.","journal-title":"J Am Coll Cardiol"},{"key":"509_CR47","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1177\/1479164109336042","volume":"6","author":"C Hage","year":"2009","unstructured":"Hage C, Norhammar A, Grip L, Malmberg K, Sarkar N, Svane B, Ryden L: Glycaemic control and restenosis after percutaneous coronary interventions in patients with diabetes mellitus: a report from the Insulin Diabetes Angioplasty study. Diab Vasc Dis Res. 2009, 6: 71-79. 10.1177\/1479164109336042.","journal-title":"Diab Vasc Dis Res"},{"key":"509_CR48","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00380-009-1160-3","volume":"25","author":"G Ndrepepa","year":"2010","unstructured":"Ndrepepa G, Keta D, Byrne RA, Schulz S, Mehilli J, Seyfarth M, Schomig A, Kastrati A: Impact of body mass index on clinical outcome in patients with acute coronary syndromes treated with percutaneous coronary intervention. Hear Vessel. 2010, 25: 27-34. 10.1007\/s00380-009-1160-3.","journal-title":"Hear Vessel"},{"key":"509_CR49","doi-asserted-by":"publisher","first-page":"e000535","DOI":"10.1136\/bmjopen-2011-000535","volume":"2","author":"L Schenkeveld","year":"2012","unstructured":"Schenkeveld L, Magro M, Oemrawsingh RM, Lenzen M, de Jaegere P, van Geuns RJ, Serruys PW, van Domburg RT: The influence of optimal medical treatment on the \u2018obesity paradox\u2019, body mass index and long-term mortality in patients treated with percutaneous coronary intervention: a prospective cohort study. BMJ Open. 2012, 2: e000535-10.1136\/bmjopen-2011-000535.","journal-title":"BMJ Open"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2840-11-82.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T19:44:03Z","timestamp":1630525443000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/1475-2840-11-82"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,17]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["509"],"URL":"https:\/\/doi.org\/10.1186\/1475-2840-11-82","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,17]]},"assertion":[{"value":"11 April 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"82"}}